Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-021938
Filing Date
2024-08-21
Accepted
2024-08-21 20:35:12
Documents
1
Period of Report
2024-08-13

Document Format Files

Seq Description Document Type Size
1 form4-08222024_120809.html 4  
1 form4-08222024_120809.xml 4 4160
  Complete submission text file 0001415889-24-021938.txt   5726
Mailing Address C/O BLCO 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address
VON ESCHENBACH ANDREW C. (Reporting) CIK: 0001536529 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39813 | Film No.: 241229911

Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Issuer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)